UnitedHealth Group Reports Third Quarter 2026 Results
UnitedHealth Group reported Q3 2026 revenues of $112.7 billion, with GAAP EPS of $4.56 (vs $2.59 a year ago) and adjusted EPS of $4.69 (vs $2.92), as earnings from operations jumped to $6.6 billion from $4.3 billion. The medical care ratio improved to 88.4% from 89.9%, aided by $610 million of favorable reserve development, while the operating cost ratio fell to 12.8% from 13.5%. Management raised full-year 2026 guidance to at least $19.50 GAAP and $20.50 adjusted EPS, and cash flows from operations were $5.1 billion, or 1.2x net income.
Key figures
- Eps
- 4.56
- Revenue
- 112694000000
- Guidance
- FY2026 GAAP EPS at least $19.50; adjusted EPS at least $20.50
- Revenue Yoy
- -0.4%
- Net margin
- 3.6%
- Buyback ytd
- 5031000000
- Adjusted eps
- 4.69
- Optum revenue
- 66883000000
- Optum earnings
- 3732000000
- Prior year eps
- 2.59
- Consumers served
- 48300000
- Dividends paid ytd
- 6170000000
- Medical care ratio
- 88.4%
- Operating cost ratio
- 12.8%
- Debt to capital ratio
- 41.7%
- Prior year adjusted eps
- 2.92
- Earnings from operations
- 6563000000
- Unitedhealthcare revenue
- 86330000000
- Unitedhealthcare earnings
- 2831000000
- Cash flows from operations q3
- 5100000000
- Favorable reserve development
- 610000000
- Medical care ratio prior year
- 89.9%
- Operating earnings prior year
- 4315000000
- Operating cost ratio prior year
- 13.5%
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.